To explore the effect of subanesthetic-dose esketamine combined with different general anesthetic drugs on the quality of postoperative recovery in patients undergoing painless gastrointestinal endoscopy.
Eligibility
Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria:
* (1) Aged between 18 and 75 years old (inclusive); (2) ASA (American Society of Anesthesiologists) physical status classification of Class I to III; (3) Body Mass Index (BMI) ranging from 18 to 30 kg/m²; (4) Individuals scheduled to undergo combined gastroscopy and colonoscopy under painless anesthesia; (5) Those with a patent airway and no history of difficult intubation or difficult airway management; (6) Individuals with intact cognitive function, who have provided informed consent, voluntarily participate in this study, and are capable of cooperating to complete data collection.
Exclusion Criteria:
* (1)A history of unregulated diabetes mellitus, hypertension, or hypotension; (2)Concomitant hyperthyroidism or hypothyroidism; (3)Concomitant psychiatric or neurological disorders; (4)Severe hepatic or renal insufficiency; (5)Concomitant glaucoma, severe hearing or visual impairment that hinders cooperation; (6)Individuals with significant organ dysfunction; (7)Those with allergies to or contraindications for the study drug; (8)Patients with aneurysmal vascular diseases involving the thoracic or abdominal aorta, intracranial arteries, or peripheral arterial vessels; (9)Individuals who are unable to cooperate in completing the Quality of Recovery-15 (QoR-15) questionnaire.
Primary outcome measure(s)
Quality of Recovery-15 — Postoperative day 1 and 3 The QoR-15 (Quality of Recovery-15) evaluates the quality of recovery across five dimensions: physical comfort (50 points), emotional state (40 points), physical independence (20 points), psychological support (20 points), and pain (20 points). The total score of the QoR-15 ranges from 0 (indicating the poorest quality of recovery) to 150 (representing the best quality of recovery).
Trial sites (1)
Facility
City
Region
Status
Northern Jiangsu People's Hospital
Yangzhou
Jiangsu
More Northern Jiangsu People's Hospital trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.